CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $169,111 | +28.7% | 13,379 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $131,382 | -1.3% | 13,379 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $133,121 | +12.6% | 13,379 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $118,270 | +124.2% | 13,379 | +49.1% | 0.00% | +100.0% |
| Q3 2019 | $52,761 | -51.0% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $107,676 | -0.6% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,304 | -3.8% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $112,611 | -15.4% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $133,159 | -11.8% | 8,973 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $151,000 | -26.3% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $205,000 | -11.6% | 8,973 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $232,000 | – | 8,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 968,198 | $9,634,000 | 3.29% |
| INGALLS & SNYDER LLC | 1,382,048 | $13,751,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,710 | $6,972,000 | 0.66% |
| Alambic Investment Management, L.P. | 17,900 | $178,000 | 0.45% |
| RA Capital Management | 1,858,474 | $18,492,000 | 0.36% |
| Perceptive Advisors | 2,150,641 | $21,398,000 | 0.35% |
| Eversept Partners, LP | 232,983 | $2,318,181 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 17,351 | $173,000 | 0.10% |
| Alyeska Investment Group, L.P. | 502,783 | $5,003,000 | 0.08% |
| KENNEDY CAPITAL MANAGEMENT LLC | 263,958 | $2,626,000 | 0.08% |